A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma-MedSci.cn

A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma

Martin, P; Bartlett, NL; Blum, KA; Park, S; Maddocks, K; Ruan, J; Ridling, L; Dittus, C; Chen, Z; Huang, X; Inghirami, G; DiLiberto, M; Chen-Kiang, S; Leonard, JP

Martin, P (reprint author), Weill Cornell Med, Dept Internal Med, 525 East 68th St, New York, NY 10021 USA.

BLOOD, 2019; 133 (11): 1201

Abstract

Single-agent ibrutinib is active in patients with previously treated mantle cell lymphoma (MCL); however, nearly half of all patients experience treat......

Full Text Link